224 related articles for article (PubMed ID: 26210509)
1. Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.
Ascherman DP
Curr Rheumatol Rep; 2015 Sep; 17(9):56. PubMed ID: 26210509
[TBL] [Abstract][Full Text] [Related]
2. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation.
Katsumata Y; Ridgway WM; Oriss T; Gu X; Chin D; Wu Y; Fertig N; Oury T; Vandersteen D; Clemens P; Camacho CJ; Weinberg A; Ascherman DP
J Autoimmun; 2007; 29(2-3):174-86. PubMed ID: 17826948
[TBL] [Abstract][Full Text] [Related]
3. A woman with anti-histidyl-aminoacyl-tRNA synthetase (Jo-1 antibodies), myositis, hyperglycemia, interstitial lung disease, and morbilliform rashes.
Tsai CY; Tsai YY; Kuo HL; Chou CT
Rheumatol Int; 2005 Mar; 25(2):156-7. PubMed ID: 14770267
[No Abstract] [Full Text] [Related]
4. Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies.
Galindo-Feria AS; Albrecht I; Fernandes-Cerqueira C; Notarnicola A; James EA; Herrath J; Dastmalchi M; Sandalova T; Rönnblom L; Jakobsson PJ; Fathi M; Achour A; Grunewald J; Malmström V; Lundberg IE
Arthritis Rheumatol; 2020 Jan; 72(1):179-191. PubMed ID: 31403245
[TBL] [Abstract][Full Text] [Related]
5. Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome.
Yamaguchi K; Tang Q; Poland P; Reay DP; Gregory A; Aggarwal R; Oddis CV; Ascherman DP
Front Immunol; 2024; 15():1399451. PubMed ID: 38895121
[TBL] [Abstract][Full Text] [Related]
6. Anti-Jo-1 autoantibodies and the immunopathogenesis of autoimmune myositis.
Tsui FW; Siminovitch KA
Int Rev Immunol; 1991; 7(3):225-35. PubMed ID: 1721933
[TBL] [Abstract][Full Text] [Related]
7. Role of innate immunity in a murine model of histidyl-transfer RNA synthetase (Jo-1)-mediated myositis.
Soejima M; Kang EH; Gu X; Katsumata Y; Clemens PR; Ascherman DP
Arthritis Rheum; 2011 Feb; 63(2):479-87. PubMed ID: 21280002
[TBL] [Abstract][Full Text] [Related]
8. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
Häussermann A; Gillissen A; Seidel W
Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
[TBL] [Abstract][Full Text] [Related]
9. Clinical spectrum of anti-Jo-1-associated disease.
Monti S; Montecucco C; Cavagna L
Curr Opin Rheumatol; 2017 Nov; 29(6):612-617. PubMed ID: 28796005
[TBL] [Abstract][Full Text] [Related]
10. The role of Jo-1 in the immunopathogenesis of polymyositis: current hypotheses.
Ascherman DP
Curr Rheumatol Rep; 2003 Dec; 5(6):425-30. PubMed ID: 14609486
[TBL] [Abstract][Full Text] [Related]
11. Purification of mammalian histidyl-tRNA synthetase and its interaction with myositis-specific anti-Jo-1 antibodies.
Fahoum SK; Yang DC
Biochemistry; 1987 Sep; 26(18):5871-7. PubMed ID: 3499936
[TBL] [Abstract][Full Text] [Related]
12. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity.
Mathews MB; Bernstein RM
Nature; 1983 Jul 14-20; 304(5922):177-9. PubMed ID: 6866113
[TBL] [Abstract][Full Text] [Related]
13. Epitope mapping of the cloned human autoantigen, histidyl-tRNA synthetase. Analysis of the myositis-associated anti-Jo-1 autoimmune response.
Ramsden DA; Chen J; Miller FW; Misener V; Bernstein RM; Siminovitch KA; Tsui FW
J Immunol; 1989 Oct; 143(7):2267-72. PubMed ID: 2476503
[TBL] [Abstract][Full Text] [Related]
14. Rat liver histidyl-tRNA synthetase. Purification and inhibition by the myositis-specific anti-Jo-1 autoantibody.
Yang DC; Dang CV; Arnett FC
Biochem Biophys Res Commun; 1984 Apr; 120(1):15-21. PubMed ID: 6712685
[TBL] [Abstract][Full Text] [Related]
15. Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF).
Mejía M; Herrera-Bringas D; Pérez-Román DI; Rivero H; Mateos-Toledo H; Castorena-García P; Figueroa JE; Rojas-Serrano J
Respir Med; 2017 Feb; 123():79-86. PubMed ID: 28137500
[TBL] [Abstract][Full Text] [Related]
16. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
[TBL] [Abstract][Full Text] [Related]
17. Antigen-driven T cell-macrophage interactions mediate the interface between innate and adaptive immunity in histidyl-tRNA synthetase-induced myositis.
Reay DP; Tabib T; Wang Y; Oriss TB; Young NA; Lafyatis RA; Jarjour WN; Clemens PR; Ascherman DP
Front Immunol; 2023; 14():1238221. PubMed ID: 37809058
[TBL] [Abstract][Full Text] [Related]
18. Histidyl-tRNA synthetase, the myositis Jo-1 antigen, is cytoplasmic and unassociated with the cytoskeletal framework.
Dang CV; LaDuca FM; Bell WR
Exp Cell Res; 1986 May; 164(1):261-6. PubMed ID: 3956597
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic plasma exchange in antisynthetase syndrome with severe interstitial lung disease.
Omotoso BA; Ogden MI; Balogun RA
J Clin Apher; 2015 Dec; 30(6):375-9. PubMed ID: 25727180
[TBL] [Abstract][Full Text] [Related]
20. The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome.
Yousem SA; Gibson K; Kaminski N; Oddis CV; Ascherman DP
Mod Pathol; 2010 Jun; 23(6):874-80. PubMed ID: 20228783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
